Terms: = Colorectal cancer AND FGFR1, CEK, 2260, ENSG00000077782, P11362, FLT2, CD331, H3, HBGFR, FGFBR, H5, KAL2, H2, BFGFR, N-SAM, H4 AND Staging
5 results:
1. Biomarkers of peripheral blood neutrophil extracellular traps in the diagnosis and progression of malignant tumors.
Wang M; Lv X; Wang Y; Li Y; Li H; Shen Z; Zhao L
Cancer Med; 2024 Feb; 13(3):e6935. PubMed ID: 38230764
[TBL] [Abstract] [Full Text] [Related]
2. B7-H3: A Useful Emerging Diagnostic Marker for Colon cancer.
Bostanci O; Sayin P; Kiziltan R; Algul S; Aydin MA; Kemik O
Biomed Res Int; 2022; 2022():1523338. PubMed ID: 36605103
[TBL] [Abstract] [Full Text] [Related]
3. MicroRNA miR-29a Inhibits Colon cancer Progression by Downregulating B7-H3 Expression: Potential Molecular Targets for Colon cancer Therapy.
Wang J; Chen X; Xie C; Sun M; Hu C; Zhang Z; Luan L; Zhou J; Zhou J; Zhu X; Ouyang J; Dong X; Li D; Zhang J; Zhao X
Mol Biotechnol; 2021 Sep; 63(9):849-861. PubMed ID: 34100183
[TBL] [Abstract] [Full Text] [Related]
4. B7-H3 expression in colorectal cancer: nuclear localization strongly predicts poor outcome in colon cancer.
Ingebrigtsen VA; Boye K; Tekle C; Nesland JM; Flatmark K; Fodstad O
Int J Cancer; 2012 Dec; 131(11):2528-36. PubMed ID: 22473715
[TBL] [Abstract] [Full Text] [Related]
5. Analysis of both NM23-h1 and NM23-H2 expression identifies "at-risk" patients with colorectal cancer.
Brenner AS; Thebo JS; Senagore AJ; Duepree HJ; Gramlich T; Ormsby A; Lavery IC; Fazio VW
Am Surg; 2003 Mar; 69(3):203-8; discussion 208. PubMed ID: 12678475
[TBL] [Abstract] [Full Text] [Related]
